X-19360739-C-CTGAT
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_001001671.4(MAP3K15):c.*9_*10insATCA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000604 in 1,192,552 control chromosomes in the GnomAD database, including 1 homozygotes. There are 21 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000071 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000059 ( 1 hom. 19 hem. )
Consequence
MAP3K15
NM_001001671.4 3_prime_UTR
NM_001001671.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.00200
Genes affected
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
MAP3K15 (HGNC:31689): (mitogen-activated protein kinase kinase kinase 15) The protein encoded by this gene is a member of the mitogen-activated protein kinase (MAPK) family. These family members function in a protein kinase signal transduction cascade, where an activated MAPK kinase kinase (MAP3K) phosphorylates and activates a specific MAPK kinase (MAP2K), which then activates a specific MAPK. This MAP3K protein plays an essential role in apoptotic cell death triggered by cellular stresses. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant X-19360739-C-CTGAT is Benign according to our data. Variant chrX-19360739-C-CTGAT is described in ClinVar as [Likely_benign]. Clinvar id is 3060782.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDHA1 | NM_000284.4 | c.*1089_*1092dup | 3_prime_UTR_variant | 11/11 | ENST00000422285.7 | ||
MAP3K15 | NM_001001671.4 | c.*9_*10insATCA | 3_prime_UTR_variant | 29/29 | ENST00000338883.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K15 | ENST00000338883.9 | c.*9_*10insATCA | 3_prime_UTR_variant | 29/29 | 5 | NM_001001671.4 | P1 | ||
PDHA1 | ENST00000422285.7 | c.*1089_*1092dup | 3_prime_UTR_variant | 11/11 | 1 | NM_000284.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000714 AC: 8AN: 112055Hom.: 0 Cov.: 24 AF XY: 0.0000584 AC XY: 2AN XY: 34233
GnomAD3 genomes
AF:
AC:
8
AN:
112055
Hom.:
Cov.:
24
AF XY:
AC XY:
2
AN XY:
34233
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000567 AC: 10AN: 176414Hom.: 0 AF XY: 0.0000321 AC XY: 2AN XY: 62394
GnomAD3 exomes
AF:
AC:
10
AN:
176414
Hom.:
AF XY:
AC XY:
2
AN XY:
62394
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000592 AC: 64AN: 1080443Hom.: 1 Cov.: 25 AF XY: 0.0000546 AC XY: 19AN XY: 347789
GnomAD4 exome
AF:
AC:
64
AN:
1080443
Hom.:
Cov.:
25
AF XY:
AC XY:
19
AN XY:
347789
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000714 AC: 8AN: 112109Hom.: 0 Cov.: 24 AF XY: 0.0000583 AC XY: 2AN XY: 34297
GnomAD4 genome
AF:
AC:
8
AN:
112109
Hom.:
Cov.:
24
AF XY:
AC XY:
2
AN XY:
34297
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PDHA1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 16, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at